Selection of Target Sites for Mobile DNA Integration in the Human Genome

Overview

Journal PLoS Comput Biol

Specialty Biology

Date 2006 Dec 15

PMID 17166054

Citations 150

Authors

Charles Berry

Sridhar Hannenhalli

Jeremy Leipzig

Frederic D Bushman

Affiliations

Soon will be listed here.

Abstract

DNA sequences from retroviruses, retrotransposons, DNA transposons, and parvoviruses can all become integrated into the human genome. Accumulation of such sequences accounts for at least 40% of our genome today. These integrating elements are also of interest as gene-delivery vectors for human gene therapy. Here we present a comprehensive bioinformatic analysis of integration targeting by HIV, MLV, ASLV, SFV, L1, SB, and AAV. We used a mathematical method which allowed annotation of each base pair in the human genome for its likelihood of hosting an integration event by each type of element, taking advantage of more than 200 types of genomic annotation. This bioinformatic resource documents a wealth of new associations between genomic features and integration targeting. The study also revealed that the length of genomic intervals analyzed strongly affected the conclusions drawn--thus, answering the question "What genomic features affect integration?" requires carefully specifying the length scale of interest.

Citing Articles

Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.

Jadlowsky J, Hexner E, Marshall A, Grupp S, Frey N, Riley J Nat Med. 2025; .

PMID: 39833408 DOI: 10.1038/s41591-024-03478-6.

Leucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors.

James S, Chen S, Ng B, Fischman J, Jahn L, Boardman A Nat Biomed Eng. 2024; 8(12):1592-1614.

PMID: 39715901 DOI: 10.1038/s41551-024-01287-3.

Modulation of AAV transduction and integration targeting by topoisomerase poisons.

Kasimsetty A, Hwang Y, Everett J, McFarland A, Zolnoski S, Lu T Mol Ther Methods Clin Dev. 2024; 32(4):101364.

PMID: 39618424 PMC: 11607603. DOI: 10.1016/j.omtm.2024.101364.

Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy.

Chappell M, Breda L, Tricoli L, Guerra A, Jarocha D, Castruccio Castracani C Blood. 2024; 144(15):1633-1645.

PMID: 38949981 PMC: 11487647. DOI: 10.1182/blood.2023023349.

Biodistribution of lentiviral transduced adipose-derived stem cells for "ex-vivo" regional gene therapy for bone repair.

Bell J, Collon K, Mayfield C, Gallo M, Chang S, Sugiyama O Gene Ther. 2023; 30(12):826-834.

PMID: 37568039 DOI: 10.1038/s41434-023-00415-z.

References

Fitzgerald M, Grandgenett D . Retroviral integration: in vitro host site selection by avian integrase. J Virol. 1994; 68(7):4314-21. PMC: 236354. DOI: 10.1128/JVI.68.7.4314-4321.1994. View

Nakai H, Wu X, Fuess S, Storm T, Munroe D, Montini E . Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver. J Virol. 2005; 79(6):3606-14. PMC: 1075691. DOI: 10.1128/JVI.79.6.3606-3614.2005. View

Lewinski M, Yamashita M, Emerman M, Ciuffi A, Marshall H, Crawford G . Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog. 2006; 2(6):e60. PMC: 1480600. DOI: 10.1371/journal.ppat.0020060. View

Narezkina A, Taganov K, Litwin S, Stoyanova R, Hayashi J, Seeger C . Genome-wide analyses of avian sarcoma virus integration sites. J Virol. 2004; 78(21):11656-63. PMC: 523270. DOI: 10.1128/JVI.78.21.11656-11663.2004. View

Barr S, Ciuffi A, Leipzig J, Shinn P, Ecker J, Bushman F . HIV integration site selection: targeting in macrophages and the effects of different routes of viral entry. Mol Ther. 2006; 14(2):218-25. DOI: 10.1016/j.ymthe.2006.03.012. View

Wu X, Li Y, Crise B, Burgess S, Munroe D . Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses. J Virol. 2005; 79(8):5211-4. PMC: 1069554. DOI: 10.1128/JVI.79.8.5211-5214.2005. View

Geurts A, Hackett C, Bell J, Bergemann T, Collier L, Carlson C . Structure-based prediction of insertion-site preferences of transposons into chromosomes. Nucleic Acids Res. 2006; 34(9):2803-11. PMC: 1464413. DOI: 10.1093/nar/gkl301. View

Miller D, Petek L, Russell D . Adeno-associated virus vectors integrate at chromosome breakage sites. Nat Genet. 2004; 36(7):767-73. DOI: 10.1038/ng1380. View

Breslow N . Statistics in epidemiology: the case-control study. J Am Stat Assoc. 1996; 91(433):14-28. DOI: 10.1080/01621459.1996.10476660. View

10.

Lander E, Linton L, Birren B, Nusbaum C, Zody M, Baldwin J . Initial sequencing and analysis of the human genome. Nature. 2001; 409(6822):860-921. DOI: 10.1038/35057062. View

11.

Wu X, Li Y, Crise B, Burgess S . Transcription start regions in the human genome are favored targets for MLV integration. Science. 2003; 300(5626):1749-51. DOI: 10.1126/science.1083413. View

12.

Vos J, de Baere I, Plasterk R . Transposase is the only nematode protein required for in vitro transposition of Tc1. Genes Dev. 1996; 10(6):755-61. DOI: 10.1101/gad.10.6.755. View

13.

Trobridge G, Miller D, Jacobs M, Allen J, Kiem H, Kaul R . Foamy virus vector integration sites in normal human cells. Proc Natl Acad Sci U S A. 2006; 103(5):1498-503. PMC: 1360565. DOI: 10.1073/pnas.0510046103. View

14.

Crawford G, Holt I, Mullikin J, Tai D, Blakesley R, Bouffard G . Identifying gene regulatory elements by genome-wide recovery of DNase hypersensitive sites. Proc Natl Acad Sci U S A. 2004; 101(4):992-7. PMC: 327130. DOI: 10.1073/pnas.0307540100. View

15.

Ciuffi A, Llano M, Poeschla E, Hoffmann C, Leipzig J, Shinn P . A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med. 2005; 11(12):1287-9. DOI: 10.1038/nm1329. View

16.

Schroder A, Shinn P, Chen H, Berry C, Ecker J, Bushman F . HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002; 110(4):521-9. DOI: 10.1016/s0092-8674(02)00864-4. View

17.

Miller D, Trobridge G, Petek L, Jacobs M, Kaul R, Russell D . Large-scale analysis of adeno-associated virus vector integration sites in normal human cells. J Virol. 2005; 79(17):11434-42. PMC: 1193581. DOI: 10.1128/JVI.79.17.11434-11442.2005. View

18.

Lampe D, Churchill M, Robertson H . A purified mariner transposase is sufficient to mediate transposition in vitro. EMBO J. 1996; 15(19):5470-9. PMC: 452289. View

19.

Ciuffi A, Mitchell R, Hoffmann C, Leipzig J, Shinn P, Ecker J . Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts. Mol Ther. 2005; 13(2):366-73. DOI: 10.1016/j.ymthe.2005.10.009. View

20.

Stevens S, Griffith J . Sequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration. J Virol. 1996; 70(9):6459-62. PMC: 190680. DOI: 10.1128/JVI.70.9.6459-6462.1996. View